Morice, A., Smith, J. A., McGarvey, L., Birring, S. S., Parker, S. M., Turner, A., Hummel, T., Gashaw, I., Fels, L., Klein, S., Francke, K., & Friedrich, C. (2021). Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: A randomised, placebo-controlled, crossover phase 2a study. European Respiratory Journal, 58(5), Article 2004240. https://doi.org/10.1183/13993003.04240-2020